| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 01/17/2008 | WO2008008359A2 Benzofuro-and benzothienopyryimidine modulators of the histamine h4 receptor |
| 01/17/2008 | WO2004106938A3 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7) |
| 01/17/2008 | US20080015360 2,3-Dimethyl-1-[(2,2,3,3-tetramethylcyclopropyl)carbonyl]-1H-imidazol-3-ium chloride; intermediate for preparing androstane-type glucocorticoid receptor agonists |
| 01/17/2008 | US20080015200 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
| 01/17/2008 | US20080015195 Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase |
| 01/17/2008 | US20080015152 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive, eating and nervous system disorders |
| 01/17/2008 | US20080014249 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 01/17/2008 | US20080014246 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/17/2008 | US20080014238 Implantable medical devices comprising semi-crystalline poly(easter-amide) |
| 01/17/2008 | US20080014237 Sustained release compositions, process for producing the same and use thereof |
| 01/17/2008 | US20080014228 Solid form |
| 01/17/2008 | DE102006031962A1 Amidiertes Insulin Glargin Amidated insulin glargine |
| 01/17/2008 | DE102006031955A1 Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende Process for the preparation of insulin analogues with dibasic B chain end |
| 01/17/2008 | CA2655499A1 Method of treating and preventing secondary hyperparathyroidism_with vitamin d repletion and vitamin d replacemnt therapies |
| 01/16/2008 | EP1878446A2 Formulation comprising buprenorphine |
| 01/16/2008 | EP1673063B1 Transdermal pharmaceutical composition |
| 01/16/2008 | EP1653947B1 (4-hydroxyphenyl)-1h-indole-3-carbaldehyde oxime derivatives as estrogenic agents |
| 01/16/2008 | EP1435929B1 Composition comprising cysteamine for improving lactation in dairy animals |
| 01/16/2008 | EP1326894B1 Novel tumor-associated marker |
| 01/16/2008 | CN101107259A Silicon compounds and their use |
| 01/16/2008 | CN101104047A Traditional Chinese medicine composition for curing hyperthyroidism |
| 01/16/2008 | CN101104045A Traditional Chinese medicine for treating thyroic disease |
| 01/15/2008 | US7319163 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism |
| 01/15/2008 | US7319096 Antiarrhythmia agents; liver disorders; skin disorders |
| 01/15/2008 | US7318931 A protein, e.g., insulin or a growth hormone; a polyol, e.g., mannitol or polyethylene glycol; and a metal, e.g., zinc; stabilized against denaturing when in contact with an organic solvent. |
| 01/15/2008 | CA2319763C Cholenic acid amides and pharmaceutical compositions thereof |
| 01/15/2008 | CA2225724C Pharmaceutical combined preparation, kit and method for hormonal contraception |
| 01/10/2008 | WO2008005980A1 Copositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism |
| 01/10/2008 | WO2008004717A1 A stable liquid formulation of human growth hormone |
| 01/10/2008 | US20080009631 e.g. 2-[4-[3-[2-(2,4-Dichlorophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy]-2-methylpropionic acid; |
| 01/10/2008 | US20080009525 Activator of peroxisome proliferator-activated receptor delta |
| 01/10/2008 | US20080009513 Therapeutic agents |
| 01/10/2008 | US20080009499 3-(2,2-Dimethyl-propyl)-5,6,7,8,9,10-hexahydro-cycloocta[c]pyridazine; 11beta-hydroxysteroid dehydrogenase (11b-HSD1) inhibitors; diabetes, obesity, eating disorders, dyslipidemiae and hypertension |
| 01/10/2008 | US20080009489 Androgen receptor modulators and method of treating disease using the same |
| 01/10/2008 | US20080009447 Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of SOCS sequence in the animal |
| 01/10/2008 | US20080008762 Steroid Formulation And Methods Of Treatment Using Same |
| 01/10/2008 | US20080008650 Endometriosis cell targeting peptide and uses thereof |
| 01/10/2008 | CA2656608A1 Compositions and methods for preventing or treating cardiovascular diseases in felines with hyperthyroidism |
| 01/09/2008 | EP1874763A2 Polymorph form ii of tanaproget |
| 01/09/2008 | EP1874355A2 Method of treatment using gh antagonist and somatostatin agonist |
| 01/09/2008 | EP1663936B1 Biaryloxymethylarene-carboxylic acids |
| 01/09/2008 | EP1385845B1 N-aroyl cyclic amines |
| 01/09/2008 | EP1324766B1 Fgf-2 for the treatment of peripheral artery disease |
| 01/09/2008 | EP0866726B2 Pulmonary administration of dry powder alpha 1-antitrypsin |
| 01/09/2008 | CN101103011A Novel 2H-chromene derivatives as selective estrogen receptormodulators |
| 01/09/2008 | CN101100480A New etonogestrel esters |
| 01/09/2008 | CN101099742A Testosterone gel preparation capable of decreasing skin irritation |
| 01/09/2008 | CN100360538C Thienopyrimidine compound and use of the same |
| 01/09/2008 | CN100360522C Novel compounds having selective inhibiting effect at GSK3 |
| 01/09/2008 | CN100360181C Sustained-release fine granular preparation of human growth hormone and process for producing the same |
| 01/09/2008 | CN100360166C Chinese medicine prepn for treating hyperthyroidosis and its prepn process |
| 01/08/2008 | US7317006 Thieno[2,3-d]pyrimidines with combined LH and FSH agonistic activity |
| 01/08/2008 | US7317002 Site-specific preparation of polyethylene glycol-GRF conjugates |
| 01/03/2008 | WO2008001959A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 01/03/2008 | WO2008000521A1 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20- spirox-4-en-3-one) and pharmaceutical preparations containing the same |
| 01/03/2008 | WO2007118198A3 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF |
| 01/03/2008 | WO2007098381A3 11-phosphorous steroid derivatives useful as progesterone receptor modulators |
| 01/03/2008 | US20080004257 Kinase inhibitors |
| 01/03/2008 | US20080004251 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor |
| 01/03/2008 | US20080004250 Use of potent antiandrogen compounds with lower androgenic activities, such as 3 beta -acetoxyandrost-1,5-diene-17-ethylene ketal (ADEK) and 3 beta -hydroxyandrost-1,5-diene-17-ethylene ketal; androgen-independent prostate cancer |
| 01/03/2008 | US20080004248 prostate cancer, benign prostatic hyperplasia, acne, seborrhea, hirsutism, androgenic alopecia, precocious puberty, adrenal hyperlasia and polycystic ovarian syndrome, breast cancer, endometriosis, leiomyoma and precocious puberty, estrogen dependent diseases |
| 01/03/2008 | US20080003680 plants and plant cells comprising of functional mammalian enzyme providing N-glycan biosynthesis that is normally not present in plants, for example mammalian beta 1,4-galactosyltransferase; glycoprotein processing in transgenic plants used as cost efficient and contamination safe factories |
| 01/03/2008 | US20080003284 Levothyroxine compositions and methos |
| 01/03/2008 | CA2656443A1 18-methyl-19-nor-androst-4-en-17,17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the same |
| 01/03/2008 | CA2656067A1 Treatment of vasomotor symptoms with selective estrogen receptor modulators |
| 01/03/2008 | CA2655913A1 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility |
| 01/02/2008 | EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/02/2008 | EP1872776A2 Mousse composition |
| 01/02/2008 | EP1871796A1 Vesiculins |
| 01/02/2008 | EP1871384A2 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
| 01/02/2008 | EP1841421A4 The use of a lignan for the manufacture of a composition for preventing or alleviating of symptoms relating to estrogen deficiency |
| 01/02/2008 | EP1458743B1 Tetrahydrobenzfluorene derivatives |
| 01/02/2008 | EP1268404B1 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 01/02/2008 | EP1254130B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 01/02/2008 | CN101095892A Medicine for treating thyroid hyperfunction disease |
| 01/02/2008 | CN100358920C Methods for identifying inducers and inhibitors of propteolytic antibodies, compositions and their uses |
| 01/02/2008 | CN100358878C Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof |
| 01/02/2008 | CN100358494C Inhalation system |
| 01/01/2008 | US7314856 Adrenomedullin agonists |
| 12/27/2007 | WO2007149010A1 Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance |
| 12/27/2007 | WO2007148494A1 Agent for increasing testosterone level |
| 12/27/2007 | WO2007147319A1 Yin-nourishing capsule |
| 12/27/2007 | US20070299090 Substituted 8-aminoalkoxy-xanthine compounds and compositions useful in the treatment of hyperlipidemia and diabetes |
| 12/27/2007 | US20070299073 Imidazolyl derivatives |
| 12/27/2007 | US20070299070 Such as 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-indole-2-carboxamide and 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-benzimidazole-2-carboxamide; melanin-concentrating hormone receptor antagonist, useful for treating obesity |
| 12/27/2007 | US20070299006 Secreted by yeast; storage stability; nonimmunogenic; vaccine; long half-life; use for growth hormone deficiency in human or animal to stimulate meat production |
| 12/27/2007 | US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
| 12/27/2007 | US20070298028 Diagnostics and Therapeutics for Diseases Associated With Kallikrein 3 (Klk3) |
| 12/27/2007 | US20070297989 Novel anti-inflammatory androstane derivatives |
| 12/27/2007 | CA2654408A1 Medicinal agent for treating fatness, diabetes, and diseases associated with impaired glucose tolerance |
| 12/26/2007 | EP1870467A1 Polypeptide hormone Phosphatonin |
| 12/26/2007 | EP1869003A1 Indazoles as glucocorticoid receptor ligands |
| 12/26/2007 | EP1868617A1 Combination of a silicon containing component and a hormone |
| 12/26/2007 | EP1868590A2 Method of increasing testosterone and related steroid concentrations in women |
| 12/26/2007 | EP1261363B1 METHODS FOR TREATING FSH RELATED CONDITIONS WITH GnRH ANTAGONISTS |
| 12/26/2007 | CN101092409A C-aryl glucoside sglt2 inhibitors and method |
| 12/26/2007 | CN101091703A Renin inhibitor-containing synergetic compositions designated for treatment of cardiovascular disease |
| 12/26/2007 | CN100357311C 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 12/26/2007 | CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 12/26/2007 | CN100356978C Novel exendin agonist formulations and methods administration thereof |